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ND license.1. Introduction
The tissue-lying Staphylococcus aureus, Streptococcus pyogenes,
Salmonella typhimurium and Escherichia coli causes food
poisoning, rheumatic, salmonellosis and diarrhea; these are
the second leading cause of death from bacterial disease world-
wide (Qadri et al., 2005). More than 50 million people world-
wide are infected and up to 150,000 die every year due to these
bacterial infections (Zhang et al., 2006). Amoxicillin, norﬂox-
acin, chloramphenicol, ciproﬂoxacin are the most common
drugs used for these bacterial infections but are associated with
severe side effects (Puertoa et al., 2006). Toxicity and resis-
tance to the drugs also play important role in the treatment
failure (Dore and Lacroix, 1987). Therefore; there is an urgent
need to screen new compounds for the development of new
anti-bacterial agents. The study of oxime-ether derivatives
have become of much interest in recent years on account of
their antiprotozoan (Brain et al., 1989), anti-bacterial (Chern
8 S.A. Khan et al.et al., 2004), antiretroviral (Emami et al., 2004), antifungal
(Jindal et al., 2003), antineoplastic (Karakurt et al., 2001)
and antimicrobial activities (Prabhu et al., 1981). Different
oxime-ether derivatives have also been reported to possess
anticholinergic (Toshio et al., 1980), insecticidal (George
et al., 1984) and acaricidal activities (Nolan et al., 1979). In
view of these observations and in continuation of our work
on synthesis and biological activity of steroidal molecules, it
was considered of interest to synthesize some new chemical
entities incorporating the active pharmacophores in a single
molecular frame work and to evaluate their biological activi-
ties. In this paper we have synthesized oxime-ethers by the
reaction of steroidal oxime (1, 2, 3) with chloroethylamine
hydrochloride/with 1-(2-chloroethyl) pyrrolidine hydrogen
chloride. The activities of these compounds were screened
in vitro against of bacterial strains.2. Experimental
The entire chemicals were purchased from Aldrich Chemical
Company (USA) and were used without further puriﬁcation.
The reactions were monitored by precoated aluminium silica
gel 60F 254 thin layer plates procured from Merck (Germany).
All melting points were measured with a capillary apparatus
and are uncorrected. All the compounds were routinely
checked by IR, 1H NMR and mass spectrometries. IR spectra
were recorded in KBr on a Perkin–Elmer model 1620 FTIR
spectrophotometer. 1H NMR spectra were recorded at ambi-
ent temperature using a Brucker spectroscopin DPX-
600 MHz spectrophotometer in DMSO. The following abbre-
viations were used to indicate the peak multiplicity s – singlet,
d – doublet, t – triplet, m – multiplet. FAB mass spectra were
recorded on a JEOL SX102 mass spectrometer using Argon/
Xenon (6 kV, 10 mB) gas. Column chromatography was per-
formed on silica gel (Merck). Anhydrous sodium sulfate was
used as a drying agent for the organic phase. Compounds 1,
2a, 3a, 1b, 2b, 3b, 1c, 2c, 3c, 1, 2 and 3 were prepared according
to published methods (Khan et al., 2008).
2.1. General procedure for the syntheses of the steroidal oxime-
ether (4–9)
To a solution of steroidal oxime (1–3) (1.09 mmol) in metha-
nol (10 ml) was added chloroethylamine hydrochloride/1-(2-
chloroethyl) pyrrolidine hydrochloride/(1.33 mmol) at room
temperature followed by a freshly prepared solution of so-
dium methoxide (0.18 ml) drop wise. The mixture was re-
ﬂuxed for 1 h. The completion of reaction was detected by
TLC. The reaction mixture was cooled, precipitate was col-
lected by ﬁltration, washed with water, air dried and residue
obtained was puriﬁed by column chromatography (20:80,
diethyl ether:petroleum ether). The compounds were recrys-
tallized with methanol.
2.2. 3b-Acetoxy-6-(20-aminoethoxyimino)-5a-cholestane (4)
Yields: 90.05; Mp: 183 C; Anal. Calc. for C31H54N2O3: C,
74.06; H, 10.82; N, 5.57. Found: C, 74.05; H, 10.84; N,
5.58%. IR (KBr) vmaxcm
1: 3472 (NH2), 1736 (OCOCH3),
1661 (C‚N), 1389 (N–O), 1298 (C–O), 1225 (C–N); 1HNMR (CDCl3) dH: 4.6 (br, m, 1H, J= 18 Hz, C3a-H, axial),
3.82 (t, 2H, J= 6.0 Hz, OCH2), 3.26 (m, 2H, NCH2), 2.8 (s,
2H, CH2NH2), 2.20 (s, OCOCH3), 0.72 (s, 3H, 13-CH3), 0.98
(s, 3H, 18-CH3), 1.12 (s, 3H, 10-CH3), and 0.84 (s, 3H, 19-
CH3); Mass spectra (M
+) at m/z 503, 444 (M–OCOCH3),
487 (M–NH2), 473 (M–NH2CH2), 459 (M–CH2CH2NH2),
453 (M–OCH2CH2NH2), 390 (M–side chain).
2.3. 3b-Chloro-6-(20-aminoethoxyimino)-5a-cholestane (5)
Yields: 70.0%; Mp: 170 C; Anal. Calc. for C29H51N2OCl: C,
72.69; H, 10.73; N, 5.80. Found: C, 73.65; H, 10.72; N,
5.88%. IR (KBr) vmaxcm
1: 3465 (NH2), 1666 (C‚N), 1382
(N–O), 1284 (C–O), 1223 (C–N), 724 (C–Cl); 1H NMR
(CDCl3) dH: 4.3 (br, m, 1H, J = 17 Hz, C3a-H, axial), 3.68
(t, 2H, J= 6.0 Hz, OCH2), 3.38 (m, 2H, NCH2), 2.5 (s, 2H,
CH2NH2), 0.74 (s, 3H, 13-CH3), 0.96 (s, 3H, 18-CH3),
1.14(s, 3H, 10-CH3), and 0.85 (s, 3H, 19-CH3); Mass spectra
(M+) at m/z 480, 464 (M–NH2), 450 (M–NH2CH2), 436
(M–CH2CH2NH2), 430 (M–OCH2CH2NH2), 367 (M–side
chain), 444 (M–Cl).
2.4. 6-(20-Aminoethoxyimino)-5a-cholestane (6)
Yields: 79.80%; Mp: 178 C; Anal. Calc. for C29H52N2O: C,
78.32; H, 11.78; N, 6.29. Found: C, 78.30; H, 11.78; N,
6.39%. IR (KBr) vmaxcm
1: 3342 (NH2), 1655 (C‚N), 1400
(N–O), 1225 (C–O), 1228 (C–N); 1H NMR (CDCl3) dH: 3.95
(t, 2H, J= 6.0 Hz, OCH2), 3.42 (t, 2H, NCH2), 2.54 (s, 2H,
CH2NH2), 0.74 (s, 3H, 13-CH3), 0.96 (s, 3H, 18-CH3),
1.14(s, 3H, 10-CH3), and 0.85 (s, 3H, 19-CH3); Mass spectra
(M+) at m/z 445, 429(M–NH2), 415 (M–NH2CH2), 401
(M–CH2CH2NH2), 395 (M–OCH2CH2NH2), 332 (M–side
chain), 444 (M–Cl).
2.5. 3b-Acetoxy-6-(2-pyroolidino ethoxy imino)-cholestane (7)
Yields: 72%; Mp: 164–166 C; Anal. Calc. for C35H60N2O3: C,
75.53; H, 10.79; N, 5.03. Found: C, 75.42; H, 10.72; N, 5.01%.
IR (KBr) vmax cm
1: 1735 (OCOCH3), 1660 (C‚N), 1375
(N–O), 1322 (C–O), 1262 (C–N). 1H NMR (CDCl3) dH: 4.72
(br, m, 1H, J= 18 Hz, C3a axial), 4.21 (t, 2H, J= 6.0 Hz
–OCH2), 3.50 (t, 2H, –NCH2), 2.89 (m, 8H, N-methylenes of
pyrrolidino functionality), 1.07 (s, 3H, 10-CH3), 0.96 (s, 3H,
18-CH3), 0.85 (s, 3H, 19-CH3) and 0.68 (s, 3H, 13-CH3); Mass
spectra (M+) at m/z 557, 498 (M–AcO), 487 (M–NC4H8), 459
(M–C6H12N), 444 (M–side chain), 429 (M–C6H12N2O).
2.6. 3b-Chloro-6-(2-pyrrolidino ethoxy imino)-cholestane (8)
Yields: 78%; Mp: 154–156 C; Anal. Calc. for C33H57N2OCl:
C, 74.29; H, 10.69; N, 5.25. Found: C, 74.24; H, 10.65; N,
5.23%. IR (KBr) vmax cm
1: 1654 (C‚N), 1383 (N–O), 1262
(C–O), 715 (C–Cl). 1H NMR (CDCl3) dH: 4.52 (br, m, 1H
w1/2 = 17 Hz, C3a-H, axial), 4.15 (t, 2H, –OCH2), 3.84 (t,
2H, –NCH2), 2.67 (8H, m, N-methylenes of pyrrolidino func-
tionality), 1.12 (s, 3H, 10-CH3), 0.93 (s, 3H, 18-CH3), 0.82 (s,
3H, 19-CH3) and 0.69 (s, 3H, 13-CH3); Mass spectra (M
+) at
534, 498 (M–Cl), 464 (M–NC4H8), 436 (M–NC6H12), 421 (M–
side chain), 406 (M–N2C6H12O).
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Yields: 78%; Mp: 160 C; Anal. Calc. for C33H58N2O: C,
79.51; H, 11.64; N, 5.62. Found: C, 78.49; H, 5.58; N,
5.61%. IR (KBr) vmaxcm
1: 1653 (C‚N), 1419 (N–O), 1282
(C–N); 1H NMR (CDCl3) dH: 4.42 (t, 2H, J= 6.2 Hz,
–OCH2), 3.62 (t, 2H, –NCH2) 2.58 (m, 8H, N-methylenes of
piperidino functionality), 1.10 (s, 3H, 10-CH3), 0.91 (s, 3H,
18-CH3), 0.82 (s, 3H, 19-CH3) and 0.68 (s, 3H, 13-CH3); Mass
spectra (M+) at m/z 499, 429 (M–C4H8N), 401 (M–C6H12N),
386 (M–side chain), 371 (M–C6H12N2O).
2.8. Organism culture and in vitro screening
Anti-bacterial activity was done by the disk diffusion method
with minor modiﬁcations. S. aureus, S. pyogenes, S. typhimuri-
um and E. coli were sub cultured in BHI medium and incu-
bated for 18 h at 37 C, and then the bacterial cells were
suspended, according to the McFarland protocol in saline
solution to produce a suspension of about 105 CFU mL1:
10 lL of this suspension was mixed with 10 mL of sterile anti-
biotic agar at 40 C and poured onto an agar plate in a laminar
ﬂow cabinet. Five paper disks (6.0 mm diameter) were ﬁxed
onto nutrient agar plate. About 1 mg of each test compound
was dissolved in 100 lL DMSO to prepare stock solution from
stock solution different concentration 10, 20, 25, 50, and
100 lg/lL of each test compound were prepared. These com-
pounds of different concentration were poured over disk plate
onto it. Chloramphenicol (30 lg/disk) was used as standard
drug (positive control). DMSO poured disk was used as nega-
tive control. The susceptibility of the bacteria to the test com-
pounds was determined by the formation of an inhibitory zone
after 18 h of incubation at 36 C (Table 1) reports the inhibi-
tion zones (mm) of each compound and the controls. The min-Table 2 Minimum inhibition concentration (MIC) of steroidal oxim
MIC (lg mL1) Compounds
Strain 4 5 6
Staphylococcus aureus 32 32 64
Streptococcus pyogenes 64 32 128
Salmonella typhimurium 64 32 128
Escherichia coli 128 32 512
Table 1 Antibacterial activity of steroidal oxime-ether derivatives,
(DMSO) measured by the Halo zone test (Unit, mm).
Compounds Corresponding eﬀect on microorganisms
S. aureus S. Pyogen
4 17.0 ± 0.4 16.5 ± 0.
5 18.5 ± 0.4 19.5 ± 0.
6 14.5 ± 0.4 13.6 ± 0.
7 15.3 ± 0.5 16.5 ± 0.
8 19.3 ± 0.2 19.8 ± 0.
9 13.4 ± 0.4 14.2 ± 0.
(Chlora.) 17.0 ± 0.5 18.2 ± 0.
DMSO – –imum inhibitory concentration (MIC) was evaluated by the
macro dilution test using standard inoculums of 105
CFL mL1. Serial dilutions of the test compounds, previously
dissolved in dimethyl sulfoxide (DMSO) were prepared to ﬁnal
concentrations of 512, 256, 128, 64, 32, 16, 8, 4, 2 and 1 lg/mL
to each tube was added 100 lL of a 24 h old inoculum. The
MIC, deﬁned as the lowest concentration of the test com-
pound, which inhibits the visible growth after 18 h, was deter-
mined visually after incubation for 18 h, at 37 C, and the
results are presented in Table 2. Tests using DMSO and chlor-
amphenicol as negative and positive controls (Scheme 1).
3. Results and discussion
3.1. Chemistry
The oxime-ether derivatives were synthesized using literature
procedure (Abid and Azam, 2006) and obtained the desired
oxime product in 70–90% yields. All the six compounds were
prepared by reﬂuxing 1:1.2 M ratio of steroidal oxime, with
chloroethylamine hydrochloride/1-(2-chloroethyl) pyrrolidine
hydrogen chloride in the presence of sodium methoxide in
dry methanol. The obtained compounds are stable in the solid
as well as in the solution state. Characteristic IR bands provide
signiﬁcant indications for the formation of steroidal oxime-
ether derivatives. The compounds (4–9) showed intense band
in the region 1653–1666 cm1 due to the v(C‚N) stretch. IR
spectra of all the compounds showed v(N–O) stretch at
1375–1419 cm1. In addition, the absorption band at 1225–
1322 cm1 was attributed to the v(C–O) stretch vibration,
which conﬁrms the formation of desired oxime-ether. The
structure of the oxime-ether derivative was further conﬁrmed
by 1H NMR spectra, which proves as a diagnostic tool for
the positional elucidation of the proton. Assignments of thee-ether derivatives, positive control: chloramphenicol.
Positive
7 8 9 Control
64 32 128 32
64 32 128 32
32 64 512 32
128 32 128 32
positive control chloramphenicol (Chlora.) and negative control
es S. typhimurium E. coli
4 17.5 ± 0.2 18.8 ± 0.5
2 21.5 ± 0.3 22.4 ± 0.4
2 12.5 ± 0.4 13.5 ± 0.4
4 14.5 ± 0.4 16.5 ± 0.4
4 22.5 ± 0.6 21.4 ± 0.4
5 14.2 ± 0.2 12.4 ± 0.5
4 17.2 ± 0.8 20.0 ± 0.2
– –
Cl
NO2NO2 NO2
O
O
Acetic acid Acetic acid Acetic acidZn dust Zn dust Zn dust
CH3COO
CH3COO
Cl
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O
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N
NOCH2CH2-R
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NH2
N
(1b) (2b)
(3b)
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acetic anhydride pyridine thionyl chloride
(3c)
Scheme 1.Showing the synthesis of Oxime ether  4-9, compound no. 4-6 R=  
(a)
(1c)
(2c)
(1) (2) (3)
(4, 7) (5,8)     (6,9)
Where  -R= and 
compound no. 7-9 R=
Compound (a): Cholesterol (1a) =3β-Acetoxycholest-5-ene, (2a) = 3β-Chlorocholest-5-ene and (3a) = 
Cholest-5ene 
Scheme 1 Schematic diagram showing the synthesis of steroidal oxime-ether derivatives.
10 S.A. Khan et al.signals are based on chemical shift and intensity pattern. The
1H NMR spectra showed two triplets in the region 3.68–
4.42 ppm for (O–CH2), and 3.26–3.84 ppm for CH2N proton,
respectively, details are given in the Section 2. Characteristic
peaks were observed in the mass spectra of all com-
pounds which followed the similar fragmentation pattern.
The spectrum of compound 4 showed molecular ion peak
(M+) at m/z-503. The characteristics peaks observed withinthe mass spectra of oxime-ether derivatives are given in
Section 2.
3.2. Pharmacology
3.2.1. Antimicrobial activity
The in vitro antimicrobial activity was performed using the
disk diffusion method and the Minimum Inhibitory Concen-
Synthesis and biological evaluation of new oxime-ether derivatives 11tration (MIC) method. Chloramphenicol was used as positive
controls for bacteria.
3.3. Disk diffusion and micro dilution assay
The compounds (4–9) were tested for their anti-bacterial activ-
ities by disk-diffusion method [22] using nutrient broth med-
ium [contained (g/L): beef extract 3 g; peptone 5 g; pH 7.0].
The Gram-positive bacteria and Gram-negative bacteria
utilized in this study consisted of S. aureus, S. pyogenes, S.
typhimurium and E. coli. In the disk-diffusion method, sterile
paper disks (0.5 mm) impregnated with compound dissolved
in dimethylsulfoxide (DMSO) at concentration 100 lg/mL
were used. Then, the paper disks impregnated with the solution
of the compound tested were placed on the surface of the
media inoculated with the microorganism. The plates were
incubated at 35 C for 24 h. After incubation, the growth inhi-
bition zones are shown in Table 1. The oxime-ether derivatives
were further checked by MIC method. The results are pre-
sented in Table 2. The molecular structure of these active com-
pounds showed enhanced activity. The distinct differences in
the anti-bacterial property of these compounds further justify
the purpose of this study. The importance of such work lies
in the possibility that the new compound might be a more
efﬁcacious drug against bacteria for which a thorough investi-
gation regarding the structure–activity relationship, toxicity
and in their biological effects which could be helpful in design-
ing more potent anti-bacterial agents for therapeutic use.
4. Conclusions
This research involves the synthesis of oxime-ether derivatives
of cholesterol. The anti-bacterial activity of these compounds
was examined using culture of bacteria and results showed that
the chloro and acetoxy substituents on the 3b-position of the
steroidal oxime-ether increased the anti-bacterial activity.
Among the entire six compounds chloro derivative showed
better anti-bacterial activity than the respective drug
chloramphenicol.Acknowledgement
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